Showing results (31-40 of 128) with videos related to

Sort By:
Pageof 13
Leukemia & Lymphoma|June 10, 2011
Effect of concomitant statin, metformin, or aspirin on rituximab treatment for diffuse large B-cell lymphomaYu Xuan Koo, Daniel S W Tan, Iain B H Tan, et al.
Cancer Research Communications|May 9, 2024
Transcriptome Deconvolution Reveals Absence of Cancer Cell Expression Signature in Immune Checkpoint Blockade ResponseYu Amanda Guo, Tanmay Kulshrestha, Mei Mei Chang, et al.
BMC Cancer|September 20, 2014
Tongue carcinoma infrequently harbor common actionable genetic alterationsDaniel S W Tan, Weining Wang, Hui Sun Leong, et al.
BMC Cancer|December 26, 2018
Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesWan-Ling Tan, Quan Sing Ng, Cindy Lim, et al.
BMC Cancer|December 5, 2018
Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesWan-Ling Tan, Quan Sing Ng, Cindy Lim, et al.
Investigational New Drugs|August 4, 2018
Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitorJames J Harding, Todd M Bauer, Daniel S W Tan, et al.
Annals of Hematology|April 27, 2011
Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxisYu Xuan Koo, Matthew Tay, Yii Ean Teh, et al.
Oncoimmunology|December 16, 2022
Bystander CD4+ T cells infiltrate human tumors and are phenotypically distinctShamin Li, Summer Zhuang, Antja Heit, et al.
Nature Methods|August 16, 2016
Single-cell multimodal profiling reveals cellular epigenetic heterogeneityLih Feng Cheow, Elise T Courtois, Yuliana Tan, et al.
The Lancet. Oncology|August 12, 2016
Novel therapeutic targets on the horizon for lung cancerWan-Ling Tan, Amit Jain, Angela Takano, et al.
Pageof 13